Reproduction and development

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 2, 1998, Pages 571-576

  Spielmann, Horst ^a,b  

^a Bundesinst fur Gesundheitlichen   (Germany)

^b BgW   (Germany)

Author keywords

Development; Embryo; Embryotoxicity; Evaluation; In vitro test; Reproduction; Toxicology; Validation

Indexed keywords

ACCURACY; CONFERENCE PAPER; DEVELOPMENT; EMBRYO CELL; EMBRYOTOXICITY; FEMALE FERTILITY; MALE FERTILITY; PRIORITY JOURNAL; REPRODUCTION; SCREENING TEST; TOXICITY TESTING; VALIDATION PROCESS;

MAMMALIA;

EID: 0031803460     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106571     Document Type: Conference Paper

References (51)

1. Villeneuve DC, Koeter HBWM, eds. Proceedings of the International Workshop on In Vitro Methods in Reproductive Toxicology. Reprod Toxicol 7:1-175 (1993).
2. Brown NA, Spielmann H, Bechter R, Flint OP, Freeman SJ, Jelinek RJ, Koch E, Nau H, Newall DR, Palmer AK et al. Screening chemicals for reproductive toxicity: the current alternatives. The report and recommendations of and ECVAM/ECTS workshop (ECVAM Workshop 12). ATLA 23:868-882 (1995).
3. OECD. OECD Guidelines for Testing of Chemicals, Guideline 421: Reproduction/Developmental Toxicity Screening Test. Paris:Organisation for Economic Co-operation and Development, 1995.
4. OECD. OECD Guidelines for Testing of Chemicals, Guideline 422: Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test. Paris :Organisation for Economic Co-operation and Development, 1996.
5. OECD. OECD Guidelines for Testing of Chemicals, Guideline 415: One-Generation Reproduction Toxicity Study. Paris:Organisation for Economic Co-operation and Development, 1983.
6. OECD. OECD Guidelines for Testing of Chemicals, Guideline 416: Two-Generation Reproduction Toxicity Study. Paris:Organisarion for Economic Co-operation and Development, 1983.
7. International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use. ICH harmonized tripartite guidelines - detection of toxicity to reproduction for medicinal products. In: Proceedings of the Second International Conference on Harmonization, Orlando 1993 (D'Arcy PF, Harron DWG, eds). Antrim, U.K.:Greystone Books, 1994;557-577.
8. Mattison DR. Sites of female reproductive vulnerability: implications for testing and risk assessment. Reprod Toxicol 7:53-62 (1993).
9. Holloway AJ, Moore HDM, Foster PMD. The use of in vitro fertilisation to detect reductions in fertility of male rats exposed to 1,3-dinitrobenzene. Fundam Appl Toxicol 14:113-122 (1990).
10. Spielmann H, Vogel R. Unique role of studies on preimplantation embryos to understand mechanisms of embryotoxicity in early pregnancy. Crit Rev Toxicol 20:51-64 (1989).
11. Morrissey RE, Schwetz BA, Lamb JC, Ross MD, Teague JL, Morris RW. Evaluation of rodent sperm, vaginal cytology and reproductive organ weight from NTP 13-week studies. Fundam Appl Toxicol 11:343-358 (1988).
12. Evenson DP. Flow cytometry of acridine orange stained sperm is a rapid and practical method for monitoring occupational exposure to genotoxicants. In: Monitoring or Occupational Genotoxicants (Sorsa M, Norppaed H, eds). New York:Alan R. Liss, 1986;121-132.
13. Evenson DP, Higgins PH, Grueneberg D, Ballachey DE. Flow cytometric analysis of mouse spermatogenic function following exposure to ethyinitrosourea. Cytometry 6:238-253 (1985).
14. Pratt RM, Grove R.I, Willis WD. Prescreening for environmental teratogens using cultured mesenchymal cells from the human embryonic palate. Teratog Carcinog Mutagen 2:313-318 (1982).
15. Braun AG, Nichinson BB, Horowicz PB. Inhibition of tumour cell attachment to concanavalin A-coated surfaces as an assay for teratogenic agents: approaches to validation. Teratog Carcinog Mutagen 2:343-354 (1982).
16. Mummery CL, van der Brink CE, van der Saag PT, De Laat SW. A short term screening test for teratogens using differentiating neuroblastoma cells in vitro. Teratology 29:271-279 (1984).
17. Steele VE, Morrissey RE, Elmore EL, Gurganus-Rocha D, Wilkinson BP, Curren RD, Schmetter BS, Louie AT, Lamb JC, Yang LIL. Evaluation of two in vitro assays to screen for potential development toxicants. Fundam Appl Toxicol 11:673-684 (1988).
18. Rohwedel J, Maltsev V, Bober E, Arnold HH, Hescheler J, Wobus AM. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol 164:87-101 (1994).
19. Heuer J, Graeber IM, Pohl I, Spielmann H. An in vitro embryotoxicity assay using the differentiation of embryonic mouse stem cells into haematopoietic cells. Toxicol In Vitro 8:585-587 (1994).
20. Laschinski G, Vogel R, Spielmann H. Cytotoxicity test usine blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. Reprod Toxicol 5:57-64 (1991).
21. Newall DR, Beedies KE. The stem-cell test - a novel in vitro assay for teratogenic potential. Toxicol In Vitro 8:697-701 (1994).
22. Speilmann H, Pohl I, Döring B, Moldenhauer F. The embryonic stem cell test (EST): an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicol 10:199-127 (1997).
23. Daston GP, Baines D, Yonker JE. Chick embryo retinal cell cultures as a screen for developmental toxicity. Toxicol Appl Pharmacol 109:352-366 (1991).
24. Umansky R. The effect of cell population density on the developmental fate of reaggregating mouse limb bud mesenchyme. Dev Biol 13:31-56 (1966).
25. Flint OP. A micromass culture method for rat embryonic neural cells. J Cell Sci 61:247-262 (1983).
26. Flint OP, Orton TC. An in vitro assay for teratogens with cultures of rat embryo midbrain and limb cells. Toxicol Appl Pharmacol 76:383-395 (1984).
27. Flint OP. In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test. Reprod Toxicol 7(Suppl 1):103-111 (1993).
28. Kistler A, Tsuchiya T, Tsuchiya M, Klaus M. Teratogenicity of arotenoids (retinoids) in vivo and in vitro. Arch Toxicol 64:616-622 (1990).
29. Flint OP, Boyle FT. Structure-teratogenicity relationships among antifungal triazoles. In: Handbook of Experimental Pharmacology. Vol 96: Chemotherapy of Fungal Disease (Ryley JF, ed). Berlin:Springer Verlag, 1986;231-249.
30. Tsuchiya T, Takahashi A, Asada S, Takakubo F, Ohsumi-Yamashita N, Eto K. Comparative study of embryotoxic action of ethylenethiourea in rat whole embryo and embryonic cell culture. Teratology 43:319-324 (1991).
31. Tsuchiya T, Nakamura A, Lio T, Takahashi A. Species differences between rats and mice in the teratogenic action of ethylenethiourea: in vivol in vitro tests and teratogenic activity of sera using an embryonic cell differentiation system. Toxicol Appl Pharmacol 109:1-6 (1991).
32. Brown LP, Foster JR, Orton TC, Flint OP, Gibson GG. Inducibility and functionality of rat embryonic/foetal cytochrome P450: a study of differentiating limb-bud and midbrain cells in vitro. Toxicol In Vitro 3:253-260 (1989).
33. Koelman HJS, Jongeling AJ, van Erp YHM, Weterings PJM, Koopmans ME, Joosten HF, van der Dobbelsteen DJ, van der Aa EM, Yih TD. International ring validation of the in vitro micromass teratogenicity test: preliminary results of three Dutch laboratories [Abstract]. Teratology 44:30A (1991).
34. Bantle JA, Fort DJ, Rayburn JR, DeYoung DJ, Bush SJ. Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens. Drug Chem Toxicol 13:267-282 (1990).
35. Jelinek R. The chick embryo toxicity screening test (CHEST). In: Methods in Prenatal Toxicology (Neubert D, Merker HJ, Kwasigroch TE, eds). Stuttgart:G. Thieme, 1977;381-386.
36. Jelinek R, Peterka M, Rychter Z. Chick embryotoxicity screening test - 130 substances tested. Ind J Exp Biol 23:588-595 (1985).
37. Sadler TW, Horton WE, Warner CW. Whole embryo culture: a screening technique for teratogens? Teratog Carcinog Mutagen 2:243-253 (1982).
38. Schmid BP. Teratogenicity testing of new drugs with the postimplantation embryo culture system. In: Concepts in Toxicology. Vol 3 (Homburger F, ed). Basel, Switzerland:Karger, 1985;46-57.
39. Ninomiya H, Kishida K, Ohno Y, Tsurumi K, Eto K. Effects of trypan blue on rat and rabbit embryos cultured in vitro. Toxicol In Vitro 7:707-717 (1993).
40. Rechter R, Teriouw GDC, Lee QP, Juchau MR. Effects of QA 208-199 and its metabolise 209-668 on embryonic development in vitro after microinjection into the exocoeiomic space or into the aminiotic cavity of cultured rat conceptuses. Teratog Carcinog Mutagen 11:185-194 (1991).
41. Klein NW, Plenefisch JD, Carey SW, Fredrickson WT, Sackett GP, Burbacher TM, Parker RM. Serum from monkeys with histories of fetal wastage causes abnormalities in cultures of whole rat embryos. Science 215:66-69 (1982)
42. Zhao J, Krafft N, Teriouw GDC, Bechter R. A model combining the whole embryo culture with human liver S9 fraction for human teratogenic prediction. Toxicol In Vitro 7:827-831 (1993).
43. Schmid BP, Trippmacher A, Bianchi A. Validation of whole embryo culture method for in vitro teratogenicity testing. In: Developments in the Science and Practice of Toxicology (Hayes AW, Schnell RC, Miyaed TS, eds). Amsterdam:Elsevier, 1983;563-566.
44. Piersma AH, Attenon P, Bechter R, Govers MJAP, Krafft N, Schmid BP, Stadler J, Verhoef A, Verseil C. Interlaboratory evaluation of embryotoxicity in the postimplantation rat embryo culture. Reprod Toxicol 9:275-280 (1995).
45. Kucera P, Cano E, Honegger P, Schilter B, Zijstra JA, Schmid B. Validation of whole chick embryo cultures, whole rat embryo cultures and aggregating embryonic brain cell cultures using six pairs of coded compounds. Toxicol In Vitro 7:785-798 (1993).
46. Bechter R, Teriouw GDC, Tsuchiya M, Tsuchiya T, Kistler A. Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture. Arch Toxicol 66:193-197 (1992).
47. Nau H. Pharmacokinetic aspects of in vitro teratogenicity studies: comparison to in vivo. In: In Vitro Methods in Developmental Toxicology: Use in Defining Mechanisms and Risk Parameters (Kimmel GL, Kochhar DM, eds). Boca Raton, FL:CRC Press, 1990;29-43.
48. Andrews JE, Ebron-McCoy M, Bojic U, Nau H, Kaviock RJ. Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos. Toxicol Appl Pharmacol 132:310-316 (1995).
49. Curren RD, Southee JA, Spielmann H, Liebsch M, Fentem J, Balls M. The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA 23:211-217 (1995).
50. Balls M, Blaauboer BJ, Fentem J, Bruner L, Combes RD, Ekwal B, Fiedler RJ, Guillouzo A, Lewis RW, Lovell DP et al. Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM Workshop 5. ATLA 23:129-147 (1995).
51. Daston GP. The theoretical and empirical case for in vitro developmental toxicity screens and potential applications. Teratology 53:339-344 (1996).